Obesity Trial, Recruiting NCT06790329 Sponsor: Chinese University of Hong Kong Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06790329
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your Body Mass Index (BMI) is between 30 and 40, or 27.5 and 40 if you are Chinese or South Asian (BMI is a measure based on your height and weight)
  • Your BMI is above 40 and you are either considered too high-risk for weight-loss surgery, or you do not wish to have surgery
  • You have already tried standard weight-loss methods — such as diet, exercise, behaviour changes, and weight-loss medications — without enough success

Who may not be able to join:

  • You have had previous surgery on your upper digestive system, such as weight-loss surgery, anti-reflux surgery, stomach removal, or oesophageal surgery
  • You have previously had a procedure called an Endoscopic Sleeve Gastroplasty (ESG) (confirm with trial site)
  • You have a condition called gastroparesis, where your stomach empties too slowly (confirm with trial site)
  • You currently smoke
  • You have used opioid painkillers (such as morphine or codeine) at any point in the last 12 months
  • You have had a previous surgical procedure on the valve at the bottom of your stomach (confirm with trial site)
  • You have a blockage anywhere in your digestive system
  • You are taking any medication that could affect your weight or how quickly your stomach empties
  • You have a serious problem with blood clotting
  • You have swollen veins in your oesophagus or stomach, or a related stomach condition caused by liver problems
  • You have an uncontrolled hormonal or gland-related condition that is causing your weight gain, such as an underactive thyroid, Cushing's syndrome, or an eating disorder
  • You have an inflammatory condition of your digestive tract, such as severe acid damage to the oesophagus, active stomach or intestinal ulcers, or Crohn's disease
  • You have or have had cancer
  • You are currently pregnant or breastfeeding
  • You are not considered medically safe to have a general anaesthetic
  • You have been assessed as having a very severe level of physical health risk (referred to as ASA grade IV or V) (confirm with trial site)
  • You have a mental health or psychiatric condition, or a problem with drug or alcohol addiction
  • Your doctor considers you unsuitable for this treatment for any other safety reason
  • You do not wish to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stephen Ng, FRCSEd(Gen), Prince of Wales Hospital, the Chinese University of Hong Kong

Phone: (852)35052956

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 December 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

Body weight

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov